Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Insulin Aspart (R-Dna Origin) And Degludec Solution 30-70; 100 Iu/Ml Flexitouch Pen / Pfs

CENTRAL HOSPITAL-ALD-MEDICAL NORTH CENTRAL RLY India has Released a tender for Insulin Aspart (R-Dna Origin) And Degludec Solution 30-70; 100 Iu/Ml Flexitouch Pen / Pfs in Pharmaceuticals. The tender was released on Oct 15, 2025.

Country - India

Summary - Insulin Aspart (R-Dna Origin) And Degludec Solution 30-70; 100 Iu/Ml Flexitouch Pen / Pfs

Deadline - Oct 21, 2025

GT reference number - 120250599

Product classification - BCG vaccines (dried)

Organization Details:

  Address - India

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 120250599

  Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: Insulin Aspart (R-Dna Origin) And Degludec Solution 30-70; 100 Iu/Ml Flexitouch Pen / Pfslocal title:: INSULIN ASPART (R-DNA ORIGIN) AND DEGLUDEC SOLUTION 30-70; 100 IU/ML FLEXITOUCH PEN / PFSContract Type: : Supply Global Tenders is not only confined to tenders but we also upload crucial information, from future prospects to past market records.

Gt Ref Id - 120250599

Deadline - Oct 21, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database